|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 508.34 USD | -1.55% |
|
-1.38% | +12.13% |
| Market Cap | 129B 112B 106B 96.3B 180B 12,359B 181B 1,270B 490B 6,283B 484B 473B 20,217B | P/E 2026 * |
52.2x | P/E 2027 * | 27.5x |
|---|---|---|---|---|---|
| Enterprise Value | 125B 109B 103B 93.1B 174B 11,948B 175B 1,228B 474B 6,075B 468B 457B 19,546B | EV / Sales 2026 * |
9.4x | EV / Sales 2027 * | 8.35x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Tradegate
| VX1 | Real-time | |
|
Xetra
| VX1 | Delayed | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
London S.E.
| 0QZU | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
CBOE
| 0QZU | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -1.55% | ||
| 1 week | -1.38% | ||
| Current month | -6.64% | ||
| 1 month | -3.76% | ||
| 3 months | +12.56% | ||
| 6 months | +12.57% | ||
| Current year | +12.13% |
| 1 week | 505.01 |  | 525.29 |
| 1 month | 505.01 | | 560.25 |
| Current year | 412.27 | | 560.25 |
| 1 year | 374.17 | | 560.25 |
| 3 years | 341.85 | | 560.25 |
| 5 years | 176.36 | | 560.25 |
| 10 years | 71.46 | | 560.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/08/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 27/08/26 | Don | Director | -6,000 | 0.0024% | ||
| 21/07/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.55% | -1.38% | +31.32% | +44.41% | 131B | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,027B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 467B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 268B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 205B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 187B | |
| Average | +0.03% | +2.81% | +26.66% | +45.21% | 373.3B | |
| Weighted average by Cap. | +0.17% | +3.00% | +35.04% | +61.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.25B 11.55B 10.91B 9.91B 18.56B 1,271B 18.64B 131B 50.42B 646B 49.77B 48.66B 2,080B | 14.53B 12.67B 11.96B 10.86B 20.35B 1,394B 20.43B 143B 55.29B 709B 54.57B 53.36B 2,280B |
| Net income | 2.53B 2.21B 2.09B 1.9B 3.55B 243B 3.57B 25B 9.65B 124B 9.52B 9.31B 398B | 4.83B 4.21B 3.98B 3.61B 6.77B 464B 6.8B 47.65B 18.39B 236B 18.15B 17.75B 758B |
| Net Debt | -4.28B -3.73B -3.52B -3.2B -5.99B -410B -6.02B -42.19B -16.28B -209B -16.07B -15.71B -671B | -7.54B -6.58B -6.21B -5.64B -10.56B -724B -10.61B -74.37B -28.7B -368B -28.32B -27.7B -1,184B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | US$508.34 | -1.55% | 2,434,825 |
| 17/09/26 | US$516.34 | +0.60% | 900,049 |
| 16/09/26 | US$513.26 | -0.27% | 638,512 |
| 15/09/26 | US$514.63 | -0.94% | 824,890 |
| 14/09/26 | US$519.51 | +0.79% | 837,109 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
